Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hepatorenal Syndrome

• NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
• Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
• Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients
• HRS-AKI Treatment With TIPS in Patients With Cirrhosis
• A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
• Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
• Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
• Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.
• Angiotensin 2 for Hepatorenal Syndrome
• Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1
• Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
• Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg
• Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1
• To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure
• The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure
• Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
• Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
• A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
• To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome
• TYPE 2 HEPATORENAL SYNDROME
• Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
• Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
• Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
• A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
• Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
• Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
• Noradrenalin vs Terlipressin in Hepatorenal Syndrome
• Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
• Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
• The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
• Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1